Hernàn Picard
Publications by Year
Research Areas
Migraine and Headache Studies, Trigeminal Neuralgia and Treatments, Psychosomatic Disorders and Their Treatments, Psoriasis: Treatment and Pathogenesis, Treatment of Major Depression
Most-Cited Works
- → A Controlled Trial of Erenumab for Episodic Migraine(2017)930 cited
- → ARISE: A Phase 3 randomized trial of erenumab for episodic migraine(2018)583 cited
- → The Role of the Cerebellum in Schizophrenia: an Update of Clinical, Cognitive, and Functional Evidences(2007)287 cited
- → A phase 2, randomized, double-blind, placebo-controlled trial of AMG 301, a pituitary adenylate cyclase-activating polypeptide PAC1 receptor monoclonal antibody for migraine prevention(2020)167 cited
- → Efficacy and safety of erenumab (AMG334) in episodic migraine patients with prior preventive treatment failure: A subgroup analysis of a randomized, double-blind, placebo-controlled study(2019)126 cited
- → Early onset of efficacy with erenumab in patients with episodic and chronic migraine(2018)96 cited
- → Vascular safety of erenumab for migraine prevention(2019)95 cited
- → Migraine-related disability, impact, and health-related quality of life among patients with episodic migraine receiving preventive treatment with erenumab(2018)87 cited
- → Long-term tolerability and nonvascular safety of erenumab, a novel calcitonin gene-related peptide receptor antagonist for prevention of migraine: A pooled analysis of four placebo-controlled trials with long-term extensions(2019)71 cited
- → One-year sustained efficacy of erenumab in episodic migraine(2020)62 cited